What's breaking now, across thousands of outlets.
Healthcare and semiconductor stocks led declines as investors digested mixed corporate results and competitive pressures, today, Oct. 13, 2026.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
As well as the reliance on AI to power further market gains, Rosenberg warned of fragilities underlying the U.S. economy
Bristol Myers Squibb recovered to $7.1B in net income while Eli Lilly more than doubled profits to $20.6B, a stark contrast in momentum that reshapes the value-versus-growth debate.
He and I were in the same Harvard class together, and spent a good deal of time talking economics together. We also were (briefly) bridge partners in a few games.
AMD's backing of Fermi's 222 MW lease signals financing momentum for AI campus infrastructure, though full funding hurdles remain ahead, Oct. 13, 2026.
Stocks bounced from session lows as speculation the Federal Reserve won’t be forced to raise rates aggressively offset lingering worries about elevated oil prices and the outlook for artificial…